Search clinical trials for: PCI-32765 (Treatment A)
Total 792 results
-
Janssen Research & Development, LLCPharmacyclics LLC.Completed
-
Janssen Research & Development, LLCPharmacyclics LLC.Completed
-
Jason Robert GotlibNational Cancer Institute (NCI)TerminatedSystemic Mastocytosis | Mast Cell Leukemia | Aggressive Systemic MastocytosisUnited States
-
University of WashingtonJanssen PharmaceuticalsActive, not recruitingRecurrent Transformed B-Cell Non-Hodgkin Lymphoma | Refractory Transformed B-Cell Non-Hodgkin LymphomaUnited States
-
National Cancer Institute (NCI)M.D. Anderson Cancer CenterTerminatedRecurrent Adult Acute Lymphoblastic Leukemia | Adult B Acute Lymphoblastic Leukemia | Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34;q11.2); BCR-ABL1United States
-
Mayo ClinicNational Cancer Institute (NCI)Active, not recruitingStage I Chronic Lymphocytic Leukemia | Stage II Chronic Lymphocytic Leukemia | Stage III Chronic Lymphocytic Leukemia | Stage IV Chronic Lymphocytic LeukemiaUnited States
-
National Cancer Institute (NCI)TerminatedHIV Infection | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma | Recurrent Adult Diffuse Small Cleaved Cell Lymphoma | Recurrent Adult Lymphoblastic Lymphoma | Recurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular... and other conditionsUnited States
-
Andrew RezvaniNational Institutes of Health (NIH); Pharmacyclics LLC.CompletedAcute Myeloid Leukemia | Acute Lymphoblastic Leukemia | Hematopoietic Cell Transplantation Recipient | Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Acute Biphenotypic LeukemiaUnited States
-
National Cancer Institute (NCI)Active, not recruitingHairy Cell Leukemia | Recurrent Hairy Cell Leukemia | Hairy Cell Leukemia VariantUnited States
-
Jennifer WoyachJanssen Scientific Affairs, LLCCompletedHematopoietic and Lymphoid Cell Neoplasm | Malignant Solid Neoplasm | Monoclonal Gammopathy of Undetermined Significance | Myelodysplastic Syndrome | Aplastic Anemia | Symptomatic COVID-19 Infection Laboratory-Confirmed | Monoclonal B-Cell LymphocytosisUnited States
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI)WithdrawnWaldenstrom Macroglobulinemia | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Chronic Lymphocytic Leukemia | B-Cell Neoplasm | Small Lymphocytic Lymphoma | Asymptomatic COVID-19 Infection Laboratory-Confirmed | Symptomatic COVID-19 Infection Laboratory-Confirmed | Chronic Lymphocytic Leukemia/Small...United States
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)Active, not recruitingRecurrent Hodgkin Lymphoma | Refractory Hodgkin Lymphoma | Classical Hodgkin LymphomaUnited States
-
University of NebraskaNational Cancer Institute (NCI)CompletedRecurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell LymphomaUnited States
-
Mayo ClinicNational Cancer Institute (NCI)Active, not recruitingRecurrent Small Lymphocytic Lymphoma | Refractory Chronic Lymphocytic Leukemia | Recurrent Chronic Lymphocytic Leukemia | Refractory Small Lymphocytic Lymphoma | Recurrent Chronic Lymphocytic Leukemia/Small Lymphocytic LymphomaUnited States
-
Janssen Research & Development, LLCPharmacyclics LLC.CompletedHealthy VolunteersUnited States
-
Kerry RogersJanssen Research & Development, LLCWithdrawnChronic Lymphocytic Leukemia | Loss of Chromosome 17p
-
National Heart, Lung, and Blood Institute (NHLBI)Active, not recruitingLeukemia | CLL (Chronic Lymphocytic Leukemia) | Leukemia, Lymphocytyc | SLL (Small Lymphocytic Lymphoma)United States
-
Steven E. CoutreCompletedRecurrent Small Lymphocytic Lymphoma | Refractory Chronic Lymphocytic Leukemia | Recurrent Chronic Lymphocytic Leukemia | Refractory Small Lymphocytic LymphomaUnited States
-
Ohio State University Comprehensive Cancer CenterActive, not recruitingChronic Lymphocytic Leukemia | Ibrutinib ResistanceUnited States
-
Kami MaddocksNational Cancer Institute (NCI)CompletedRecurrent Mantle Cell Lymphoma | Recurrent Marginal Zone Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Refractory Mantle Cell Lymphoma | Recurrent Burkitt Lymphoma | Recurrent... and other conditionsUnited States
-
Janssen Research & Development, LLCCompletedHepatic ImpairmentUnited States
-
Northwestern UniversityNational Cancer Institute (NCI); Janssen Scientific Affairs, LLCActive, not recruitingStage III Mantle Cell Lymphoma | Stage IV Mantle Cell Lymphoma | Contiguous Stage II Mantle Cell Lymphoma | Noncontiguous Stage II Mantle Cell Lymphoma | Stage I Mantle Cell LymphomaUnited States
-
Janssen-Cilag Farmaceutica Ltda.Approved for marketingB-cell Chronic Lymphocytic LeukemiaBrazil
-
Jennifer WoyachActive, not recruitingChronic Lymphocytic LeukemiaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingMantle Cell LymphomaUnited States
-
Robert LowskyNational Cancer Institute (NCI); Janssen, LP; The Leukemia and Lymphoma Society; Rising Tide FoundationCompletedMantle Cell Lymphoma | Marginal Zone Lymphoma | Recurrent Follicular Lymphoma | Refractory Follicular Lymphoma | Grade 1 Follicular Lymphoma | Grade 2 Follicular Lymphoma | Grade 3a Follicular LymphomaUnited States
-
Dana-Farber Cancer InstitutePharmacyclics LLC.CompletedWaldenstrom's MacroglobulinemiaUnited States
-
M.D. Anderson Cancer CenterPharmacyclics LLC.Active, not recruitingChronic Lymphocytic Leukemia | Malignant Neoplasms Stated as Primary Lymphoid Haematopoietic | Small Lymphocytic LeukemiaUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)WithdrawnRecurrent Small Lymphocytic Lymphoma | Prolymphocytic Leukemia | Recurrent Non-Hodgkin Lymphoma | Recurrent Chronic Lymphocytic LeukemiaUnited States
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Grade 3 Follicular Lymphoma | Refractory Follicular Lymphoma | Grade 3a Follicular LymphomaUnited States, Canada, Singapore
-
M.D. Anderson Cancer CenterCompletedChronic Lymphocytic LeukemiaUnited States
-
Janssen Research & Development, LLCPharmacyclics LLC.CompletedLymphomaUnited States, Australia, France, Poland, United Kingdom, Spain, Belgium, Germany, Russian Federation
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedRecurrent Mantle Cell Lymphoma | Refractory Mantle Cell LymphomaUnited States
-
Dana-Farber Cancer InstituteTG Therapeutics, Inc.; The Leukemia and Lymphoma Society; Blood Cancer Research...Active, not recruitingMantle Cell Lymphoma | Chronic Lymphocytic Leukemia/Small Lymphocytic LymphomaUnited States
-
Emory UniversityNovartisTerminatedRecurrent Small Lymphocytic Lymphoma | Refractory Chronic Lymphocytic Leukemia | Recurrent Chronic Lymphocytic Leukemia | Refractory Small Lymphocytic LymphomaUnited States
-
Mayo ClinicNot yet recruitingChronic Graft Versus Host Disease | Hematopoietic and Lymphatic System NeoplasmUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingRecurrent Mantle Cell Lymphoma | Recurrent Marginal Zone Lymphoma | Recurrent Small Lymphocytic Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Refractory Chronic Lymphocytic Leukemia | Recurrent Non-Hodgkin Lymphoma | Refractory Non-Hodgkin Lymphoma | Richter Syndrome and other conditionsUnited States
-
National Cancer Institute (NCI)Active, not recruitingMetastatic Melanoma | Stage IV Cutaneous Melanoma AJCC v6 and v7 | Recurrent Cutaneous MelanomaUnited States
-
Mayo ClinicActive, not recruitingMetastatic Melanoma | Stage III Cutaneous Melanoma AJCC v7 | Stage IV Cutaneous Melanoma AJCC v6 and v7 | Stage IIIC Cutaneous Melanoma AJCC v7 | Unresectable Melanoma | Stage IIIA Cutaneous Melanoma AJCC v7 | Stage IIIB Cutaneous Melanoma AJCC v7United States
-
OHSU Knight Cancer InstituteGenentech, Inc.; Oregon Health and Science UniversityCompletedRecurrent Mantle Cell Lymphoma | Refractory Mantle Cell LymphomaUnited States
-
Brian JonasNational Cancer Institute (NCI); Celgene; Pharmacyclics LLC.CompletedPreviously Treated Myelodysplastic Syndrome | Myelodysplastic Syndrome | Therapy-Related Myelodysplastic Syndrome | Secondary Myelodysplastic Syndrome | Refractory High Risk Myelodysplastic SyndromeUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Small Lymphocytic Lymphoma | Refractory Chronic Lymphocytic Leukemia | Recurrent Chronic Lymphocytic Leukemia | Refractory Small Lymphocytic Lymphoma | Recurrent B-Cell Prolymphocytic Leukemia | Refractory B-Cell Prolymphocytic LeukemiaUnited States
-
Ohio State University Comprehensive Cancer CenterActive, not recruitingClassical Hodgkin LymphomaUnited States
-
M.D. Anderson Cancer CenterAmgen; Pharmacyclics LLC.Terminated
-
Jennifer WoyachKaryopharm Therapeutics IncActive, not recruitingRecurrent Adult Diffuse Large Cell Lymphoma | Recurrent Mantle Cell Lymphoma | Recurrent Small Lymphocytic Lymphoma | Prolymphocytic Leukemia | Refractory Chronic Lymphocytic LeukemiaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Pharmacyclics LLC.Completed
-
Pharmacyclics LLC.Janssen Research & Development, LLCCompletedFollicular Lymphoma | B Cell Lymphoma | Non-Hodgkin's Lymphoma | Burkitt Lymphoma | Waldenstrom Macroglobulinemia | Mantle Cell Lymphoma | B-cell Chronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma | Diffuse Well-differentiated Lymphocytic Lymphoma | B-Cell Diffuse LymphomaUnited States
-
Pharmacyclics LLC.CompletedB-cell Chronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States
-
Pharmacyclics LLC.CompletedB-Cell Leukemia | B-Cell LymphomaUnited States
-
Dana-Farber Cancer InstituteCompletedWaldenstrom's MacroglobulinemiaUnited States